Literature DB >> 19042933

Enhanced geographically restricted surveillance simulates sporadic Creutzfeldt-Jakob disease cluster.

Genevieve M Klug1, Handan Wand, Alison Boyd, Matthew Law, Scott Whyte, John Kaldor, Colin L Masters, Steven Collins.   

Abstract

Spatio-temporal clustering of sporadic Creutzfeldt-Jakob disease (sCJD) has been recognized and investigated previously in various global settings including Australia. Generally, despite often extensive investigation, explanations such as point source outbreaks and plausible case-to-case transmission links have not been identified to explain the apparently higher case rates than expected. In the context of national surveillance during the period 1993-2006, an increased number of cases of sCJD were recognized in a circumscribed coastal region of eastern Australia. To assess the significance of this apparent clustering, the Spatial Scan Statistic was used to examine for geographic excess of CJD mortality at spatial and temporal combined, spatial only and temporal only levels. A significant spatial cluster was confirmed, encompassing three contiguous statistical local areas within the state of New South Wales (NSW). Detailed epidemiological analysis did not reveal a plausible cross-over or point source transmission event. Further evaluation prompted the conclusion that vigilant and motivated managing clinicians in this geographically circumscribed area of NSW evinced a sustained higher level of clinical awareness for the broad phenotypic spectrum of CJD with reliable referral of suspect cases for further investigation. In addition, these physicians established and maintained a well-coordinated and active approach to suspect CJD autopsy. This combination of factors translated into a higher intensity of surveillance at approximately twice the rate per population observed in the entire state, culminating in twice the incidence of sCJD at around 2.28 cases/million population/year. The hypothesis that intensity of surveillance for rare disorders can be objectively measured and that this can positively correlate with disease incidence deserves further exploration. It may prove to be an important insight into the varying incidence rates over periods of time within individual nations and between different countries.

Entities:  

Mesh:

Year:  2008        PMID: 19042933     DOI: 10.1093/brain/awn303

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  7 in total

1.  Sporadic Creutzfeldt-Jakob disease: early signs and pre-mortem diagnosis.

Authors:  Etienne Laverse; Shahid Shah; Milica Mavra
Journal:  BMJ Case Rep       Date:  2009-12-07

2.  Interventions to reduce the risk of surgically transmitted Creutzfeldt-Jakob disease: a cost-effective modelling review.

Authors:  Matt Stevenson; Lesley Uttley; Jeremy E Oakley; Christopher Carroll; Stephen E Chick; Ruth Wong
Journal:  Health Technol Assess       Date:  2020-02       Impact factor: 4.014

3.  Role of magnetic resonance imaging, cerebrospinal fluid, and electroencephalogram in diagnosis of sporadic Creutzfeldt-Jakob disease.

Authors:  Leo H Wang; Robert C Bucelli; Erica Patrick; Dhanashree Rajderkar; Enrique Alvarez Iii; Miranda M Lim; Gabriela Debruin; Victoria Sharma; Sonika Dahiya; Robert E Schmidt; Tammie S Benzinger; Beth A Ward; Beau M Ances
Journal:  J Neurol       Date:  2012-09-12       Impact factor: 4.849

4.  Management and prevention of human prion diseases.

Authors:  Silvia Graziano; Maurizio Pocchiari
Journal:  Curr Neurol Neurosci Rep       Date:  2009-11       Impact factor: 5.081

Review 5.  The importance of ongoing international surveillance for Creutzfeldt-Jakob disease.

Authors:  Neil Watson; Jean-Philippe Brandel; Alison Green; Peter Hermann; Anna Ladogana; Terri Lindsay; Janet Mackenzie; Maurizio Pocchiari; Colin Smith; Inga Zerr; Suvankar Pal
Journal:  Nat Rev Neurol       Date:  2021-05-10       Impact factor: 42.937

6.  Diagnostic accuracy of cerebrospinal fluid protein markers for sporadic Creutzfeldt-Jakob disease in Canada: a 6-year prospective study.

Authors:  Michael B Coulthart; Gerard H Jansen; Elina Olsen; Deborah L Godal; Tim Connolly; Bernard C K Choi; Zheng Wang; Neil R Cashman
Journal:  BMC Neurol       Date:  2011-10-27       Impact factor: 2.474

7.  Overview and evaluation of 15 years of Creutzfeldt-Jakob disease surveillance in Belgium, 1998-2012.

Authors:  Amber Litzroth; Patrick Cras; Bart De Vil; Sophie Quoilin
Journal:  BMC Neurol       Date:  2015-12-02       Impact factor: 2.474

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.